About this trial
Obesity has become a major global public health issue, defined by an excessive accumulation of body fat that presents substantial health risks. Over 650 million adults worldwide suffer from obesity, which is defined as having a Body Mass Index (BMI) of 30 or higher. Obesity is becoming more common in both developed and developing countries. Sedentary lifestyles, unhealthy eating habits that include processed foods and sugars, and genetic factors are the main causes of the rising prevalence of obesity. Obesity is a multifactorial condition that affects physical appearance and self-esteem, while also having significant implications for long-term health, leading to decreased life expectancy and lower quality of life.
Eligibility criteria
Qualifiers
Females aged 18 to 25.
normotensive (<140/90 mmHg).
Their BMI was from 25 to 40 kg/m2.
Sedentary (≤ 90min of regular exercise per week).
Disqualifiers
Having previously diagnosed with any chronic disease.
Cardiorespiratory or neuromuscular conditions.
Participating in any exercise program.
Patients with a pacemaker.
Trial design
Treatments tested in this trial
- Whole-body vibration device
- Sham whole body vibration
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.